Biểu đồ giá cổ phiếu IDYA
IDYA Thu nhập
IDEAYA Biosciences Inc
$28.32
0.28%
$0.08
Khi đóng cửa: May 08, 16:00:00 GMT-4
$28.01
-1.09%
$-0.3
Phiên sau giờ: May 08, 20:00:00 GMT-4
Quay lại
IDEAYA Biosciences Inc (IDYA) Thu nhập
Thống kê chính
Giá đóng cửa trước
$28.24
Giá mở cửa
$28.2
Phạm vi ngày
$28.01 - $28.63
Phạm vi 52 tuần
$16.82 - $39.28
Khối lượng
514.1K
Khối lượng trung bình
1.0M
Tỷ suất cổ tức
--
EPS (TTM)
-1.30
Vốn hóa thị trường
$2.4B
IDYA là gì?
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The company is headquartered in South San Francisco, California and currently employs 145 full-time employees. The company went IPO on 2019-05-23. The firm is engaged in the discovery, development, and commercialization of transformative therapies for cancer. Its product candidates focus on synthetic lethality and antibody-drug conjugates (ADCs) for molecularly defined solid tumor indications. Its product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE161 (PARG), IDE275 (Werner Helicase) and IDE705 (Pol Theta Helicase). Darovasertib is a clinical stage, potent and selective small molecule inhibitor of PKC, a protein kinase that functions downstream of the GTPases GNAQ and GNA11. IDE397 is an oral small molecule inhibitor of methionine adenosyl transferase 2a (MAT2A). IDE161 is an oral small molecule poly (ADP-ribose) glycohydrolase (PARG) inhibitor. IDE275 is an oral small molecule inhibitor of the helicase domain of the Werner protein (WRN), a RecQ enzyme involved in the maintenance of genome integrity.
